GB0115182D0 - Medicaments - Google Patents
MedicamentsInfo
- Publication number
- GB0115182D0 GB0115182D0 GB0115182A GB0115182A GB0115182D0 GB 0115182 D0 GB0115182 D0 GB 0115182D0 GB 0115182 A GB0115182 A GB 0115182A GB 0115182 A GB0115182 A GB 0115182A GB 0115182 D0 GB0115182 D0 GB 0115182D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- medicaments
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0115182A GB0115182D0 (en) | 2001-06-20 | 2001-06-20 | Medicaments |
PCT/GB2002/002817 WO2002102392A1 (en) | 2001-06-20 | 2002-06-19 | Use of adenosine a1 receptor agonists for the treatment of nociceptive pain |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0115182A GB0115182D0 (en) | 2001-06-20 | 2001-06-20 | Medicaments |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0115182D0 true GB0115182D0 (en) | 2001-08-15 |
Family
ID=9917075
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0115182A Ceased GB0115182D0 (en) | 2001-06-20 | 2001-06-20 | Medicaments |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0115182D0 (en) |
WO (1) | WO2002102392A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040087642A1 (en) * | 2002-10-24 | 2004-05-06 | Zeldis Jerome B. | Methods of using and compositions comprising a JNK inhibitor for the treatment, prevention, management and/or modification of pain |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9813554D0 (en) * | 1998-06-23 | 1998-08-19 | Glaxo Group Ltd | Chemical compounds |
GB9930077D0 (en) * | 1999-12-20 | 2000-02-09 | Glaxo Group Ltd | Medicaments |
GB9930075D0 (en) * | 1999-12-20 | 2000-02-09 | Glaxo Group Ltd | Medicaments |
GB9930085D0 (en) * | 1999-12-20 | 2000-02-09 | Glaxo Group Ltd | Medicaments |
GB9930083D0 (en) * | 1999-12-20 | 2000-02-09 | Glaxo Group Ltd | Medicaments |
GB9930071D0 (en) * | 1999-12-20 | 2000-02-09 | Glaxo Group Ltd | Medicaments |
GB9930079D0 (en) * | 1999-12-20 | 2000-02-09 | Glaxo Group Ltd | Medicaments |
GB9930082D0 (en) * | 1999-12-20 | 2000-02-09 | Glaxo Group Ltd | Medicaments |
-
2001
- 2001-06-20 GB GB0115182A patent/GB0115182D0/en not_active Ceased
-
2002
- 2002-06-19 WO PCT/GB2002/002817 patent/WO2002102392A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2002102392A1 (en) | 2002-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0112834D0 (en) | Medicaments | |
AU2002365120A8 (en) | Medicaments | |
GB0104534D0 (en) | Pharmaceutical combination | |
GB0009605D0 (en) | Medicaments | |
GB0002312D0 (en) | Medicaments | |
GB0128415D0 (en) | Medicaments | |
GB0102902D0 (en) | Medicaments | |
GB0124523D0 (en) | Pharmaceutical combination | |
GB0024362D0 (en) | Medicaments | |
GB0129270D0 (en) | Pharmaceutical combination | |
GB0129397D0 (en) | Pharmaceutical combination | |
GB0015324D0 (en) | Medicaments | |
GB0105469D0 (en) | Medicaments | |
GB0129395D0 (en) | Pharmaceutical combination | |
GB0115182D0 (en) | Medicaments | |
GB0119030D0 (en) | Medicaments | |
GB0101502D0 (en) | Medicaments | |
GB0125056D0 (en) | Medicaments | |
GB0125057D0 (en) | Medicaments | |
GB0125058D0 (en) | Medicaments | |
GB0125233D0 (en) | Medicaments | |
GB0126637D0 (en) | Medicaments | |
GB0124538D0 (en) | Medicaments | |
GB0129056D0 (en) | Medicaments | |
GB0101414D0 (en) | Medicaments |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |